Functional activation of Gαq/11 protein via α1 -adrenoceptor in rat cerebral cortical membranes

Clin Exp Pharmacol Physiol. 2019 Jun;46(6):567-574. doi: 10.1111/1440-1681.13084. Epub 2019 Apr 7.

Abstract

Although it is recognized that α1 -adrenoceptors are coupled to diverse intracellular signalling pathways, its primary transduction mechanisms are evoked by activating phospholipase C in the cell membrane through Gαq/11 , resulting in production of inositol 1,4,5-trisphosphate and diacylglycerol. However, there have been few studies that indicate directly the involvement of Gαq/11 proteins in this signalling pathway in the central nervous system. In the current study, we tried to pharmacologically characterize (-)-adrenaline-stimulated [35 S]GTPγS binding to Gαq/11 in rat brain membranes. Functional activation of Gαq/11 coupled to α1 -adrenoceptor was investigated by using [35 S]GTPγS binding/immunoprecipitation assay in the membranes prepared from rat cerebral cortex, hippocampus, and striatum. The specific [35 S]GTPγS binding to Gαq/11 was stimulated by (-)-adrenaline in a concentration-dependent and saturable manner in rat cerebral cortical membranes. In hippocampal or striatal membranes, the stimulatory effects of (-)-adrenaline were scarce. The effect of (-)-adrenaline was potently inhibited by prazosin, a potent and selective α1 -adrenoceptor antagonist, but not by yohimbine, a selective α2 -adrenoceptor antagonist. The response was mimicked by cirazoline, but not by R(-)-phenylephrine. Although oxymetazoline also stimulated the specific [35 S]GTPγS binding to Gαq/11 as an apparent "super-agonist", detailed pharmacological characterization revealed that its agonistic properties in this experimental system were derived from off-target effects on 5-HT2A receptors, but not via α1 -adrenoceptors. In conclusion, functional coupling of α1 -adrenoceptors to Gαq/11 proteins are detectable in rat brain membranes by means of [35 S]GTPγS binding/immunoprecipitation assay. It is necessary to interpret the experimental data with caution when oxymetazoline is included as an agonist at α1 -adrenoceptors.

Keywords: 5-HT2A receptor; G-protein; adrenaline; oxymetazoline; α1-Adrenoceptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-1 Receptor Antagonists / pharmacology
  • Animals
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism*
  • Cerebral Cortex / cytology*
  • Epinephrine / pharmacology
  • GTP-Binding Protein alpha Subunits, Gq-G11 / metabolism*
  • Guanosine 5'-O-(3-Thiotriphosphate) / metabolism
  • Male
  • Oxymetazoline / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Adrenergic, alpha-1 / metabolism*
  • Signal Transduction / drug effects

Substances

  • Adrenergic alpha-1 Receptor Antagonists
  • Receptors, Adrenergic, alpha-1
  • Guanosine 5'-O-(3-Thiotriphosphate)
  • Oxymetazoline
  • GTP-Binding Protein alpha Subunits, Gq-G11
  • Epinephrine